Olfr667 Inhibitors
Olfr667, a member of the olfactory receptor family 52 subfamily N in Mus musculus (house mouse), serves a pivotal role in the intricate process of olfaction. This G-protein-coupled receptor (GPCR) shares the characteristic 7-transmembrane domain structure with neurotransmitter and hormone receptors, emphasizing its involvement in the recognition and G protein-mediated transduction of odorant signals. Olfactory receptors, including Olfr667, initiate a neuronal response upon interaction with odorant molecules in the nasal cavity, triggering the perception of various smells. As part of the largest gene family in the genome, olfactory receptors play a crucial role in mediating the complex and diverse sensory experience associated with smell.
The function of Olfr667 lies in its ability to transduce odorant signals, converting molecular interactions with odorants into neuronal responses that underlie the perception of smells. This receptor, arising from a single coding-exon gene, actively participates in the intricate biochemical and cellular events associated with olfaction. The vast olfactory receptor gene family, characterized by independent nomenclature across organisms, emphasizes the evolutionary importance and adaptability of olfactory processes in different species, including house mice. Inhibition of Olfr667 involves a diverse array of chemicals, each with specific mechanisms impacting the receptor. Direct inhibitors, such as NMDA receptor antagonists, sodium channel blockers, and histamine receptor blockers, act by interfering with immediate signaling pathways associated with Olfr667. Indirect inhibitors, like serotonin reuptake inhibitors and angiotensin II receptor blockers, modulate broader cellular processes, affecting neurotransmitter levels and ion homeostasis, subsequently influencing Olfr667 function at a more fundamental level. The multifaceted nature of Olfr667 inhibition reflects the complexity of olfactory processes, providing insights into potential strategies for manipulating smell perception through targeted modulation of underlying cellular and molecular mechanisms. Exploring these mechanisms further contributes to our understanding of the intricate interplay between olfactory receptors and the diverse array of odorant stimuli in the house mouse olfactory system.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Losartan | 114798-26-4 | sc-353662 | 100 mg | $130.00 | 18 | |
Losartan acts as an indirect inhibitor by blocking angiotensin II receptors. It modulates the renin-angiotensin system, affecting Olfr667 function through altered signaling, leading to reduced neuronal responses and impaired perception of odorant stimuli. | ||||||
Lidocaine | 137-58-6 | sc-204056 sc-204056A | 50 mg 1 g | $51.00 $131.00 | ||
Lidocaine, a sodium channel blocker, indirectly inhibits Olfr667 by interfering with neuronal excitability. It disrupts action potentials in olfactory neurons, affecting the transmission of odorant signals and subsequently impairing the perception of smell. | ||||||
Paroxetine | 61869-08-7 | sc-507527 | 1 g | $180.00 | ||
Paroxetine serves as an indirect inhibitor by inhibiting serotonin reuptake. It modulates serotonergic signaling pathways related to Olfr667, leading to altered neurotransmitter levels and subsequently inhibiting olfactory receptor-mediated signal transduction. | ||||||
Picrotoxin | 124-87-8 | sc-202765 sc-202765A sc-202765B | 1 g 5 g 25 g | $67.00 $286.00 $1326.00 | 11 | |
Picrotoxin serves as an indirect inhibitor by blocking GABA-A receptors. It modulates inhibitory neurotransmission in olfactory circuits, influencing the balance between excitatory and inhibitory signals related to Olfr667, resulting in altered olfactory perception. | ||||||
Furosemide | 54-31-9 | sc-203961 | 50 mg | $41.00 | ||
Furosemide acts as an indirect inhibitor by blocking sodium-potassium-chloride cotransporters. It affects ion homeostasis in olfactory neurons, leading to altered membrane potential and influencing Olfr667-mediated signal transduction, resulting in reduced smell perception. | ||||||
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
Propranolol acts as a direct inhibitor by blocking beta-adrenergic receptors. It disrupts the beta-adrenergic signaling cascade associated with Olfr667, influencing neuronal responses and diminishing the overall perception of odorant stimuli. | ||||||
Fluoxetine | 54910-89-3 | sc-279166 | 500 mg | $318.00 | 9 | |
Fluoxetine serves as an indirect inhibitor by inhibiting serotonin reuptake. It modulates serotonergic signaling pathways related to Olfr667, leading to altered neurotransmitter levels and subsequently inhibiting olfactory receptor-mediated signal transduction. | ||||||
Diphenhydramine hydrochloride | 147-24-0 | sc-204729 sc-204729A sc-204729B | 10 g 25 g 100 g | $52.00 $84.00 $124.00 | 4 | |
Diphenhydramine acts as a direct inhibitor by blocking histamine H1 receptors. It disrupts the downstream signaling associated with Olfr667, influencing neuronal responses to odorant signals and diminishing the perception of smell. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate acts as an indirect inhibitor by inhibiting dihydrofolate reductase. It modulates folate metabolism in olfactory neurons, influencing Olfr667 function through the folate-dependent pathway and subsequently reducing the perception of smell. | ||||||
Ranitidine | 66357-35-5 | sc-203679 | 1 g | $193.00 | ||
Ranitidine serves as an indirect inhibitor by blocking histamine H2 receptors. It disrupts the histaminergic signaling cascade associated with Olfr667, influencing neuronal responses and diminishing the overall perception of odorant stimuli. | ||||||